Envestnet Asset Management Inc First Trust Nyse Arca Biotechn Transaction History

Envestnet Asset Management Inc

$302 Billion
Q3 2024

A detailed history of Envestnet Asset Management Inc transactions in First Trust Nyse Arca Biotechn stock. As of the latest transaction made, Envestnet Asset Management Inc holds 108,677 shares of FBT stock, worth $18.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

108,677

Previous 50,092 116.95%

Holding current value

$18.2 Million

Previous $7.71 Million 142.24%

% of portfolio

0.01%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$152.39 - $172.91 $8.93 Million - $10.1 Million	58,585 Added 116.95%	108,677 $18.7 Million
Q2 2024 Aug 08, 2024	SELL	$141.52 - $156.4 $201,807 - $223,026	-1,426 Reduced 2.77%	50,092 $7.71 Million
Q1 2024 May 13, 2024	SELL	$145.08 - $160.46 $458,742 - $507,374	-3,162 Reduced 5.78%	51,518 $7.92 Million
Q4 2023 Feb 13, 2024	BUY	$132.5 - $158.45 $1.77 Million - $2.12 Million	13,354 Added 32.31%	54,680 $8.64 Million
Q3 2023 Nov 13, 2023	SELL	$145.69 - $157.89 $746,224 - $808,712	-5,122 Reduced 11.03%	41,326 $6.05 Million
Q2 2023 Aug 04, 2023	BUY	$151.19 - $159.79 $545,795 - $576,841	3,610 Added 8.43%	46,448 $7.11 Million
Q1 2023 May 11, 2023	SELL	$147.92 - $165.37 $981,745 - $1.1 Million	-6,637 Reduced 13.41%	42,838 $6.64 Million
Q4 2022 Feb 07, 2023	BUY	$132.87 - $159.04 $391,567 - $468,690	2,947 Added 6.33%	49,475 $7.63 Million
Q3 2022 Nov 10, 2022	BUY	$128.6 - $149.75 $259,129 - $301,746	2,015 Added 4.53%	46,528 $6.14 Million
Q2 2022 Aug 03, 2022	SELL	$123.32 - $155.54 $374,152 - $471,908	-3,034 Reduced 6.38%	44,513 $6.03 Million
Q1 2022 May 04, 2022	SELL	$137.27 - $163.07 $186,687 - $221,775	-1,360 Reduced 2.78%	47,547 $7.09 Million
Q4 2021 Feb 04, 2022	SELL	$153.09 - $169.84 $1.69 Million - $1.88 Million	-11,061 Reduced 18.44%	48,907 $7.92 Million
Q3 2021 Oct 07, 2021	SELL	$164.82 - $176.04 $4.98 Million - $5.32 Million	-30,201 Reduced 33.49%	59,968 $9.96 Million
Q2 2021 Aug 04, 2021	SELL	$157.67 - $176.2 $671,201 - $750,083	-4,257 Reduced 4.51%	90,169 $15.6 Million
Q1 2021 May 04, 2021	SELL	$156.06 - $184.84 $3.13 Million - $3.71 Million	-20,083 Reduced 17.54%	94,426 $15.2 Million
Q4 2020 Feb 02, 2021	SELL	$152.75 - $174.52 $703,108 - $803,315	-4,603 Reduced 3.86%	114,509 $19.2 Million
Q3 2020 Oct 09, 2020	BUY	$150.39 - $180.07 $940,689 - $1.13 Million	6,255 Added 5.54%	119,112 $18.7 Million
Q2 2020 Jul 08, 2020	BUY	$127.11 - $171.8 $2.06 Million - $2.78 Million	16,180 Added 16.74%	112,857 $18.9 Million
Q1 2020 Apr 23, 2020	BUY	$114.56 - $156.02 $2.05 Million - $2.79 Million	17,901 Added 22.72%	96,677 $12.7 Million
Q4 2019 Feb 11, 2020	BUY	$120.34 - $154.01 $100,002 - $127,982	831 Added 1.07%	78,776 $11.7 Million
Q3 2019 Oct 17, 2019	BUY	$123.44 - $131.99 $178,370 - $190,725	1,445 Added 1.89%	77,945 $9.65 Million
Q2 2019 Aug 02, 2019	BUY	N/A	23,172 Added 43.45%	76,500 $10.8 Million
Q1 2019 May 10, 2019	BUY	N/A	8,595 Added 19.21%	53,328 $8.05 Million
Q4 2018 Feb 13, 2019	BUY	N/A	33,780 Added 308.41%	44,733 $5.56 Million
Q3 2018 Nov 14, 2018	SELL	N/A	-10,983 Reduced 50.07%	10,953 $1.74 Million
Q2 2018 Aug 10, 2018	BUY	N/A	1,774 Added 8.8%	21,936 $3.07 Million
Q1 2018 May 09, 2018	BUY	N/A	260 Added 1.31%	20,162 $2.66 Million
Q4 2017 Feb 20, 2018	BUY	N/A	230 Added 1.17%	19,902 $2.48 Million
Q3 2017 Nov 13, 2017	SELL	N/A	-295 Reduced 1.48%	19,672 $2.44 Million
Q2 2017 Aug 14, 2017	BUY	N/A	19,967	19,967 $2.28 Million

Others Institutions Holding FBT

# of Institutions

271

Shares Held

3.61M

Call Options Held

25.5K

Put Options Held

View Full List

About FIRST TRUST NYSE ARCA BIOTECHN

Ticker FBT
Sector ETFs
Industry ETFs

More about FBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Account

Envestnet Asset Management Inc First Trust Nyse Arca Biotechn Transaction History